Institution statistics

FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 15
As coordinator: 0
As participant: 4
Sole participant: 11
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 8.417.792 8.000.000 9.197.792 4 1
2019 490.324 9.986.186 698.824 3 1
2018 4.166.157 0 4.166.157 3
2016 0 4.999.299 4.999.299 2
2015 1.999.906 0 1.999.906 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Constancy:

Total number of partners:28

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 28

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-11-01Mechanisms of human mRNA packaging and export RNApaxportcoordinator1.500.0001
2020-09-01Uncovering molecular mechanisms of active transcriptional repression. UMMATRcoordinator174.1671
2020-01-01Vienna International Postdoctoral Program VIP-2coordinator4.965.3001
2020-01-01New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms REANIMAparticipant8.000.00012
2020-01-01High-throughput 4D imaging for nanoscale cellular studies NANO4LIFEcoordinator1.778.3251
2019-10-01Diagnostic drug response-profiling using SLAMseq SLAM-Dxcoordinator150.0001
2019-04-01Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells IRF4 Degradationcoordinator174.1671
2019-03-01Investigating the pathogenic mechanisms underlying TUBB2B-related brain malformations using induced pluripotent stem cells and cerebral organoids. MiniBRAINcoordinator166.1571
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-06-01Sleep homeostasis in Caenorhabditis elegans WORM_SLEEPcoordinator166.1571
2018-03-01Rational combination therapies for metastatic cancer CombaTCancercoordinator1.500.0001
2018-01-01Transcriptional control of plasma cell development and function PlasmaCellControlcoordinator2.500.0001
2016-10-01Molecular mechanisms of cohesin-mediated sister chromatid cohesion and chromatin organization CohesinMolMechparticipant2.500.0001
2016-10-01No stress with pArg: Mechanisms of a distinct phospho-mark to coordinate stress response and protein quality control pArg_deg_signalparticipant2.499.2991
2015-09-01Identification and functional characterization of mammalian enhancers and transcriptional co-factors during cellular signaling and cell fate transitions Enhancer IDcoordinator1.999.9061
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum